FI892579A - Cykloalkylsubstituerade glutaramid -diuretiska aemnen. - Google Patents
Cykloalkylsubstituerade glutaramid -diuretiska aemnen. Download PDFInfo
- Publication number
- FI892579A FI892579A FI892579A FI892579A FI892579A FI 892579 A FI892579 A FI 892579A FI 892579 A FI892579 A FI 892579A FI 892579 A FI892579 A FI 892579A FI 892579 A FI892579 A FI 892579A
- Authority
- FI
- Finland
- Prior art keywords
- glutaramid
- diuretiska
- cycloalkylsubstituerade
- aemnen
- diuretiska aemnen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888812597A GB8812597D0 (en) | 1988-05-27 | 1988-05-27 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
FI892579A0 FI892579A0 (fi) | 1989-05-26 |
FI892579A true FI892579A (fi) | 1989-11-28 |
Family
ID=10637649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI892579A FI892579A (fi) | 1988-05-27 | 1989-05-26 | Cykloalkylsubstituerade glutaramid -diuretiska aemnen. |
Country Status (15)
Country | Link |
---|---|
US (2) | US4960792A (fi) |
EP (1) | EP0343911A3 (fi) |
JP (1) | JPH0242047A (fi) |
KR (1) | KR900017994A (fi) |
CN (1) | CN1038103A (fi) |
AU (1) | AU601332B2 (fi) |
DD (1) | DD283807A5 (fi) |
DK (1) | DK257089A (fi) |
FI (1) | FI892579A (fi) |
GB (1) | GB8812597D0 (fi) |
HU (1) | HU202194B (fi) |
IL (1) | IL90344A0 (fi) |
NO (1) | NO892140L (fi) |
PL (1) | PL279614A1 (fi) |
PT (1) | PT90645A (fi) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
GB8926512D0 (en) * | 1989-11-23 | 1990-01-10 | Pfizer Ltd | Therapeutic agents |
GB9000725D0 (en) * | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
GB9004260D0 (en) * | 1990-02-26 | 1990-04-18 | Pfizer Ltd | Therapeutic agents |
AU1870292A (en) * | 1991-04-16 | 1992-11-17 | Schering Corporation | Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity |
US5298492A (en) * | 1992-08-04 | 1994-03-29 | Schering Corporation | Diamino acid derivatives as antihypertensives |
US5208236A (en) * | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
CA2309341A1 (en) * | 1997-11-24 | 1999-06-03 | Merck & Co., Inc. | Substituted .beta.-alanine derivatives as cell adhesion inhibitors |
JP2005022976A (ja) * | 2001-07-18 | 2005-01-27 | Ajinomoto Co Inc | カルボン酸誘導体 |
US7468390B2 (en) | 2002-01-17 | 2008-12-23 | Novartis Ag | Methods of treatment and pharmaceutical composition |
US7899527B2 (en) * | 2004-05-13 | 2011-03-01 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase |
US20100260669A1 (en) * | 2004-05-13 | 2010-10-14 | Anthony Joonkyoo Yun | Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System |
AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
SI2887961T1 (sl) | 2012-08-24 | 2021-08-31 | Novartis Ag | Zaviralci NEP za zdravljenje bolezni, značilnih po atrialni širitvi ali preoblikovanju |
WO2017033128A1 (en) | 2015-08-25 | 2017-03-02 | Novartis Ag | Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors |
US20180311241A1 (en) | 2015-10-29 | 2018-11-01 | Cadila Healthcare Limited | Pharmaceutical synergistic combination |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3981915A (en) * | 1971-12-17 | 1976-09-21 | American Home Products Corporation | Amides of 1-aminocyclopentane carboxylic acid |
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
GB8811873D0 (en) * | 1988-05-19 | 1988-06-22 | Pfizer Ltd | Therapeutic agents |
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
-
1988
- 1988-05-27 GB GB888812597A patent/GB8812597D0/en active Pending
-
1989
- 1989-05-08 US US07/349,025 patent/US4960792A/en not_active Expired - Lifetime
- 1989-05-19 IL IL90344A patent/IL90344A0/xx unknown
- 1989-05-23 EP EP19890305180 patent/EP0343911A3/en not_active Withdrawn
- 1989-05-24 PT PT90645A patent/PT90645A/pt not_active Application Discontinuation
- 1989-05-24 PL PL27961489A patent/PL279614A1/xx unknown
- 1989-05-25 HU HU892672A patent/HU202194B/hu not_active IP Right Cessation
- 1989-05-25 DD DD89328909A patent/DD283807A5/de not_active IP Right Cessation
- 1989-05-26 FI FI892579A patent/FI892579A/fi not_active Application Discontinuation
- 1989-05-26 DK DK257089A patent/DK257089A/da not_active Application Discontinuation
- 1989-05-26 AU AU35240/89A patent/AU601332B2/en not_active Expired - Fee Related
- 1989-05-26 NO NO89892140A patent/NO892140L/no unknown
- 1989-05-27 KR KR1019890007117A patent/KR900017994A/ko not_active Application Discontinuation
- 1989-05-27 CN CN89103709A patent/CN1038103A/zh active Pending
- 1989-05-29 JP JP1135708A patent/JPH0242047A/ja active Pending
-
1990
- 1990-06-14 US US07/538,357 patent/US5036104A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU601332B2 (en) | 1990-09-06 |
HUT50106A (en) | 1989-12-28 |
DD283807A5 (de) | 1990-10-24 |
CN1038103A (zh) | 1989-12-20 |
AU3524089A (en) | 1989-11-30 |
PT90645A (pt) | 1989-11-30 |
PL279614A1 (en) | 1989-12-11 |
IL90344A0 (en) | 1989-12-15 |
GB8812597D0 (en) | 1988-06-29 |
EP0343911A2 (en) | 1989-11-29 |
KR900017994A (ko) | 1990-12-20 |
US5036104A (en) | 1991-07-30 |
NO892140D0 (no) | 1989-05-26 |
NO892140L (no) | 1989-11-28 |
US4960792A (en) | 1990-10-02 |
EP0343911A3 (en) | 1991-01-16 |
DK257089A (da) | 1990-01-25 |
FI892579A0 (fi) | 1989-05-26 |
DK257089D0 (da) | 1989-05-26 |
JPH0242047A (ja) | 1990-02-13 |
HU202194B (en) | 1991-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68906637D1 (de) | Wafertraeger. | |
DE58905119D1 (de) | Heteroaryloxyessigsaeure-n-isopropylanilide. | |
FI880043A0 (fi) | Lastenhet. | |
DE68921898D1 (de) | Ringbinder. | |
DE58904437D1 (de) | Rakelfarbwerk. | |
DE58904326D1 (de) | Rakelfarbwerk. | |
DE68903708D1 (de) | Spielkasten. | |
FI892579A (fi) | Cykloalkylsubstituerade glutaramid -diuretiska aemnen. | |
DE58902774D1 (de) | Pflanztafel. | |
DE68909215D1 (de) | Laseroszillator. | |
DE58903112D1 (de) | Kannenstock. | |
DE68901775D1 (de) | Mammographiegeraet. | |
FI83400B (fi) | Faestningsklaemma. | |
DE58903712D1 (de) | Gegenseheinrichtung. | |
DE58900554D1 (de) | Aminoguanidinoazine. | |
FI80861B (fi) | Plastdosa. | |
DE58908380D1 (de) | Benzofuranylbiphenyle. | |
ATE86241T1 (de) | Indanderivate. | |
DE68905196D1 (de) | Faschine. | |
ES1007733Y (es) | Arqueta. | |
DE68904912D1 (de) | Ringlaser-kreisel. | |
ES1008248Y (es) | Billar-bolera. | |
FI83355B (fi) | Loksnoeplog. | |
ES1004162Y (es) | Salero-pimentero. | |
ES1005477Y (es) | Braga-compresa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: PFIZER INC. |